Emerging Nanomaterials for Healthcare An Interdisciplinary Conference at the University of Warwick
|
|
- Gary Holland
- 5 years ago
- Views:
Transcription
1 Emerging Nanomaterials for Healthcare An Interdisciplinary Conference at the University of Warwick Mathew P. Robin *, Gemma-Louise Davies Department of Chemistry, University of Warwick, Coventry, UK *Correspondence: Abstract Emerging Nanomaterials for Healthcare, a one-day conference held at the University of Warwick on 28 November 2014, brought together over 80 academics, postgraduates and industrialists from 17 institutions and organisations from across the UK. The aim of the meeting was to provide an interdisciplinary forum to discuss research towards solving current problems in healthcare using smart treatments based on nanomaterials. In addition to stories of success, an emphasis was also placed on lessons learned, as well as visions for future directions in this rapidly expanding field. Seven speakers and over twenty poster presentations directed discussion throughout the day, while the meeting closed with an interactive panel discussion. Keywords: Nanoparticles, nanomedicine, nanomaterials, healthcare, medicine Copyright: The Authors. This article is issued under the terms of the Creative Commons Attribution Non- Commercial Share Alike License, which permits use and redistribution of the work provided that the original author and source are credited, the work is not used for commercial purposes and that any derivative works are made available under the same license terms. Emerging Nanomaterials for Healthcare An Interdisciplinary Conference at the University of Warwick In a recent editorial for the journal Angewandte Chemie, Younan Xia asked the question Are we entering the Nano Era? (Xia, 2014: 12268). Specifically, Xia was pondering whether we have reached the stage where materials fabricated with nanometre dimensions (between one and one hundred billionths of a metre) will begin to dominate technological advances in all areas of science. The importance of nanomaterials to the scientific community, and the impact of the nanotechnology that these materials enable, is a consequence of a unique set of features possessed by matter at the nanometre scale. As Stark et al. have recently noted: Valuable chemical industry products are a result of designing a set of properties within a material. Today, industrial development therefore considers nanoparticles as an extended 321
2 toolbox containing traditionally difficult to realize properties (Stark et al., 2015: 2). Despite the growing importance of nanotechnology to the areas of catalysis, pigments and composite materials, significantly less commercial success has so far been achieved for nanomaterials in healthcare. In his piece, Xia frames the driving forces for interest in nanotechnology applied to biomedical research in particular, saying cells are packed with complex, functional structures with at least one dimension on the nanoscale (Xia, 2014: 12268) and therefore the power of nanomedicine lies in its ability to operate on the same molecular scale as the intimate biochemical functions involved in the growth, development, and aging of the human body (Xia, 2014: 12269). However it is this power, derived from the complexity of the potential interactions between synthetic nanomaterials and intimate biological functions that has slowed the translation of nanomaterials to practical medical application. Not only do desirable modes of action need to be intimately understood, but the toxicity of nanomaterials must also be fully addressed. The development of nanomaterials for healthcare is a particularly pressing question for the two of us (MPR and GLD), as we both hold Fellowships from the Institute of Advanced Study at the University of Warwick, focussed toward undertaking nanotechnology-based research in the Department of Chemistry. With this concept in mind, we aimed to organise a conference that would bring together researchers working to advance the use of artificial nanomaterials in healthcare applications giving rise to the event Emerging Nanomaterials for Healthcare, which took place at the University of Warwick on 28 November One of the great challenges in this field is the number of traditional disciplines which the research typically spans; from the physical understanding of the properties of nanoparticles, to the chemistry of their fabrication, and the biology of their action as therapeutic species. For this reason, a multidisciplinary conference provided an ideal forum for the exchange of ideas and expertise, as well as an opportunity to develop the kind of collaborative research networks that are vital for success in this field. We chose to invite seven speakers whose expertise spanned a range of topics across synthetic chemistry, materials science and biology and whose research shares the common goal of understanding and developing tools to improve the diagnosis and treatment of disease for the betterment of human health. Synthetic chemistry is often divided into two distinct disciplines; organic chemistry pertaining to man-made compounds and materials which primarily contain those elements found in natural organic matter (principally carbon, oxygen, hydrogen and nitrogen), and inorganic chemistry which investigates compounds based on metallic elements 322
3 (for example iron, gold, cobalt and many more besides). Professor Nguyễn T.K. Thanh from University College London used her talk to highlight some of her research group s efforts to fabricate a wide variety of inorganic particles with sub-100 nm dimensions from metallic elements. Thanh demonstrated that her team have been able to achieve control over both the size and shape of particles (with spheres, cubes, rods, and even stars manufactured with incredible control over reproducibility) as well as variations in particle surface coatings and the layering of multiple metallic elements. Such metal nanoparticles have applications in medical diagnosis; as their magnetic character can allow them to function as contrast agents in magnetic resonance imaging (MRI), improving the detection efficiency and therefore the quality of the images produced. Thanh presented recent work where this tactic had been used to improve the study of neural stem cell engineering, with the ultimate target of achieving spinal cord reconstruction. Dr Catherine Berry from the University of Glasgow works very closely with biological cell lines, with the aim of understanding how nanosized materials interact with human cells and tissues. She presented work which utilises magnetic metal nanoparticles for magnetofection, whereby clinicians would be able to control the movement of nanoparticles through a patient s body towards the area of diseased tissue (such as a tumour) by using an external magnetic field. Research from the Berry group has focussed on coupling this concept with the use of cell penetrating peptides (naturally occurring signalling molecules that allow material to cross the cell membrane and enter cells) so that the metal nanoparticles could be directed exclusively to diseased cells and subsequently gain entry. Work in this field has the ultimate goal of eliminating the unpleasant side-effects of chemotherapy, which result from the non-specific action of cancer cell killing drugs thus resulting in the simultaneous death of cancerous and healthy cells during treatment. This strategy is a common theme in nanomedicine research, and indeed several other speakers presented a variety of approaches to achieve the goal of specificity in treatment. In addition to using an external stimulus, the presence of certain biomolecules or the natural differences in the local environments between different areas of tissue and within cells can also be exploited as a trigger for directed drug delivery. In his talk, Dr Seb Spain from the University of Nottingham (now at the University of Sheffield) demonstrated how nanoparticles can be designed to respond to specific deoxyribonucleic acid (DNA) sequences. DNA is the building blocks of genes which contain the instructions for the development and function of living organisms, and DNA communicates these instructions by interacting with the biomolecules that make up the machinery of the 323
4 cell. Crucial to Spain s research was the attachment of specific DNA sequences to polymers; synthetic organic materials that can be designed to mimic natural surfactants such as lipids (the main component of cell membranes) in their ability to assemble into agglomerates on the nanometre scale. The resulting hybrid DNA-polymer nanoparticles subsequently showed a response to complementary DNA, which could therefore allow them to use the over expression of certain DNA sequences (such as occurs in cancers) as a trigger for treatment specificity. As well as being targeted as an indicator of disease, nucleic acids can also be utilised for therapy. The presentation from Dr David Fulton of Newcastle University highlighted his recent efforts to achieve the controlled delivery of nucleic acid therapeutic agents using polymer nanoparticles. The assembly of polymers into particles on the nanometre scale allows them to be loaded with a cargo, such as molecules of a drug compound, while forming a protective layer around this cargo to prevent unwanted clearance from the body by the immune system or the action of the kidneys. The motive for using this well-established technique in Fulton s research is the attempt to improve the circulation time within the blood (and therefore the potency) of cancer therapy which uses short interfering ribonucleic acids (sirnas). These sirnas serve to silence the action of a particular gene, for example those which are specific to the division and growth of cancer cells, therefore leading to selective death of only the diseased cancerous cells. Also focussing on the use of polymer nanoparticles for drug delivery was Professor Marina Resmini from Queen Mary University of London. Recent work from her group has concentrated on using nanoparticles for transdermal drug delivery, which are topical treatments that enter the body by crossing through the skin rather than by an oral or intravenous administration. This is typically a challenging mode of action for therapy, as the skin has evolved to provide a robust barrier against foreign bodies in order to protect internal tissue from toxic and pathogenic materials. The polymer nanoparticles developed by Resmini s team were labelled with a fluorescent dye, a material that absorbs light of higher energy (such as blue light) and emits light of a lower energy (such as green light). This fluorescent tag enabled the location of the nanoparticles to be tracked using confocal microscopy (which couples conventional light microscopy with fluorescence detection) following administration to the skin surface, allowing monitoring of the passage of the nanoparticles across the skin, and their ultimate distribution within the tissue below and hence a thorough understanding of their behaviour and potential as delivery agents. 324
5 The challenge of advanced diagnosis was addressed by the final two speakers. Dr Matthew Gibson and Daniel Phillips from the University of Warwick both discussed how they have used hybrids of metal (gold) nanoparticles, surface coated with organic polymers to create sensors for diagnostic applications. In both cases the choice of gold nanoparticles was motivated by the fact that they can be manipulated to give an easy to assess visual readout. Due to an effect known as surface plasmon resonance, a solution of gold nanoparticles will change colour if the individual nanoparticles begin to agglomerate into clusters. Phillips exploited this feature to produce a colorimetric test for levels of ferrous iron (Fe 3+ ions), of interest due to the atypically high levels of Fe 3+ linked to a number of diseases, such as Alzheimer s and Parkinson s. Ferrous iron sequestering units attached to a polymer immobilised onto the surface of gold nanoparticles led to particle agglomeration in the presence of high levels of Fe 3+ ions, due to interparticle bridging. This resulted in the characteristic colour change from the gold nanoparticles, thus providing a simple readout for diagnosis. Gibson presented work that uses a similar approach for the detection of bacterial toxins. In this case, the gold nanoparticle s polymer shell can selectively bind to the toxin (a model for highly poisonous ricin ), which again leads to particle agglomeration and the diagnostic colour change. As Gibson explained in the introduction to his talk, the use of gold nanoparticles in diagnostic tests is well established, with the Clearblue pregnancy test arguably the words most ubiquitous diagnostic test based on similar technology. In fact, as Xia points out nano is nothing new at all. Before it became a buzzword, people had already used nanomaterials for many decades, if not centuries (Xia, 2014: 12268). Simple and versatile chemistry such as that based on gold nanoparticles will inevitably continue to find applications in emerging nanomaterials for healthcare. The conference closed with our speakers participating in a lively panel discussion, fielding questions from the assembled delegates. Perhaps the most pressing issue raised was the importance of working in collaborative research groups. Despite the majority of the panel identifying as Chemists, there was a clear imperative to work in collaboration with research groups possessing expertise in Biology, Life Sciences, as well as clinicians and members of the pharmaceutical industry. In the words of one panel member, it is important to avoid inventing challenges because they offer an opportunity to do interesting chemistry, only to find that a problem never existed in the first place. Instead, research should be directed by dialogue between the various disciplines to identify a clear need in the first instance. Another point on which the panel were agreed was the importance of testing materials in biologically relevant conditions early in their development. For example, 325
6 a nanoparticle formulation intended as an intravenous treatment which is insoluble in blood has no future, and it is essential to discover this sooner rather than later. The panel discussion finished with the speakers suggesting advances and directions for research that they hope to see tackled in the near future. Answers included the desire for a standardised test for the efficacy of drug release from nanoparticle delivery agents to enable comparison of data obtained by researchers working on similar problems across the globe, and a desire for a more complete understanding of the whole body immune system response to nanoparticles, which must surely be required for nanomedicine to become a clinical and commercial success. The conference Emerging Nanomaterials for Healthcare gave a great demonstration of the exciting possibilities for synthetic nanomaterials to be applied to solve problems in healthcare. Talks from our invited speakers, poster presentations from over twenty of the delegates, and the panel discussion illustrated the strength and depth of current nanomedicine research in the UK. We hope to see the field continue to expand in the coming years, with increasing numbers of nanomaterial therapies and diagnostics appearing in the clinic. As Xia concludes, only when this relatively new and still seemingly bizarre realm of nano is able to make a positive and long-lasting impact on every aspect of our society, can we finally declare the arrival of the nano era (Xia, 2014: 12271). We would like to extend our thanks to the conference sponsors: Institute of Advanced Study, University of Warwick; Materials Global Research Priority, University of Warwick; Materials Chemistry Division, Royal Society of Chemistry; Nanoscale and Journal of Materials Chemistry B, Royal Society of Chemistry; the Polymer Club, University of Warwick; ATG Scientific. More details and photographs from the Emerging Nanomaterials for Healthcare 2014 Meeting can be found at References Xia, Y. (2014), Are We Entering the Nano Era?, Angew. Chemie Int. Ed., 53 (46), Stark, W. J.; Stoessel, P. R.; Wohlleben, W.; Hafner, A. (2015), Industrial applications of nanoparticles, Chem. Soc. Rev., DOI: /c4cs00362d 326
7 To cite this article: Robin, M. P & Davies, G. (2015). Emerging Nanomaterials for Healthcare An Interdisciplinary Conference at the University of Warwick. Exchanges: The Warwick Research Journal, 2(2), Retrieved from: 327
2.3 Quantum Dots (QDs)
2.3 Quantum Dots (QDs) QDs are inorganic nanocrystals, approximately 1 10 nm in size, with unique optical properties of broad excitation, narrow size-tunable emission spectra, high photochemical stability,
More informationSelf-assembly of oligonucleotides
Self-assembly of oligonucleotides Dr. K. Uma Maheswari Professor, School of Chemical & Biotechnology SASTRA University Joint Initiative of IITs and IISc Funded by MHRD Page 1 of 9 Table of Contents 1 APPLICATIONS
More informationNANOONCOLOGY: DRUG DELIVERY IN NEUROLOGICAL CANCERS. By Ian Kanterman BME281
NANOONCOLOGY: DRUG DELIVERY IN NEUROLOGICAL CANCERS By Ian Kanterman BME281 Introduction Nanooncology is the application of Nanomedicine to cancer diagnosis and treatment. Has the potential to alter clinical
More informationBioengineering (BIOE)
Bioengineering (BIOE) 1 Bioengineering (BIOE) Courses BIOE 5301. Biosignals. 3 Credit Hours. This course offers a deep overview of the signals in the Biomedical fields. Signals are studied in several modalities,
More informationQuantitative Analysis of Scientific Publications Output on Nanotechnology - A Multidisciplinary Research
International Journal of NanoScience and Nanotechnology. ISSN 0974-3081 Volume 4, Number 2 (2013), pp. 145-152 International Research Publication House http://www.irphouse.com Quantitative Analysis of
More informationRoyal Society of Chemistry Response to the House of Commons Science and Technology Committee Call For Evidence: Antimicrobial Resistance
Royal Society of Chemistry Response to the House of Commons Science and Technology Committee Call For Evidence: Antimicrobial Resistance The Royal Society of Chemistry is the world s leading chemistry
More informationNanotechnology and Advanced Materials for more effective Healthcare
Nanotechnology and Advanced Materials for more effective Healthcare This challenge taps into the potential of nanotechnologies and advanced materials to enable more effective therapies and diagnostics
More informationCurbing Carcinoma using Nanotechnology
e t International Journal on Emerging Technologies (Special Issue on NCRIET-2015) 6(2): 266-273(2015) ISSN No. (Print) : 0975-8364 ISSN No. (Online) : 2249-3255 Curbing Carcinoma using Nanotechnology Rahul
More informationSingapore nanotechnology combats fatal brain infections
P ublic release date: 28-Jun-2009 Contact: Cathy Yarbrough sciencematter@yahoo.com 858-243-1814 Agency for Science, Technology and Research (A*STAR), Singapore Singapore nanotechnology combats fatal brain
More informationNanotechnology in Human And Veterinary Medicine. By Phoebe Parker
Nanotechnology in Human And Veterinary Medicine By Phoebe Parker Paper Based On Pathology Lectures Vetsix 2004 The background to this paper comes from the pathology lectures held at the Vetsix Conference
More informationHealthcare. Healthcare. The Centre for Process Innovation. From innovation to commercialisation
Healthcare Healthcare The Centre for Process Innovation From innovation to commercialisation The Centre for Process Innovation From innovation to commercialisation The Centre for Process Innovation (CPI)
More informationThe Integrated Biomedical Sciences Graduate Program
The Integrated Biomedical Sciences Graduate Program at the university of notre dame Cutting-edge biomedical research and training that transcends traditional departmental and disciplinary boundaries to
More informationNANO TECHNOLOGY AND MATERIAL SCIENCE EXPO Propel New Technologies by Integrating Nanoscience and Material structures
NANO TECHNOLOGY AND MATERIAL SCIENCE EXPO 2017 Propel New Technologies by Integrating Nanoscience and Material structures DUBAI, December 04-06, 2017 Contact Us nanoscience@linkinscience.com 649 Mission
More informationUNIVERSITY OF ROME LA SAPIENZA NANOTECHNOLOGIES ENGINEERING NANOPARTICLES IN BIOMEDICINE
UNIVERSITY OF ROME LA SAPIENZA NANOTECHNOLOGIES ENGINEERING NANOPARTICLES IN BIOMEDICINE Challenges The challenges are: in-situ analysis and in vivo at micro level recognize biomolecules functionality
More informationEE 45X Biomedical Nanotechnology. Course Proposal
EE 45X Biomedical Nanotechnology 1 Introduction Jie Chen ECERF W6-019 492-9820 jchen@ece.ualberta.ca Oct. 15, 2008 The purpose of this document is to propose a new course in the area of Biomedical Nanotechnology
More informationNanotechnology: A Brief History and Its Convergence with Medicine. Weston Daniel, PhD Director of Program Management
Nanotechnology: A Brief History and Its Convergence with Medicine Weston Daniel, PhD Director of Program Management Outline Introduction The Nanoscale Applications Realization of a Vision There s Plenty
More informationCourse Code: BMEG5100 Course Title: Advanced Medical Robotics Course Code: BMEG5110 Course Title: Advanced Medical Devices and Sensor Networks
Course Code: BMEG5100 Course Title: Advanced Medical Robotics Review of medical robotics fundamentals; introduction to robotics enabled endoscopic and laparoscopic surgeries; concepts of robotics based
More informationEXECUTIVE SUMMARY. vfa/vfa bio-position Paper Nanobiotechnology/Nanomedicine
vfa/vfa bio-position Paper Nanobiotechnology/Nanomedicine EXECUTIVE SUMMARY Nanotechnology is characterized by the fact that it uses materials ranging between 1 and 100 nanometers. A nanometer is the millionth
More informationBIOFILMS. Research Center for Biointerfaces. With focus on Surfaces in Clinical and Industrial applications
BIOFILMS Research Center for Biointerfaces With focus on Surfaces in Clinical and Industrial applications 2 - Biofilms Research Center Biofilms Research Center - 3 Biofilms Research Center for Biointerfaces
More informationAdvanced Biomaterials and Nanotechnologies in Drug Delivery
NANOTECHNOLOGY & ADVANCED MATERIALS SYMPOSIUM Advanced Biomaterials and Nanotechnologies in Drug Delivery Date : 25 September 2015 (Friday) Time : 2:00pm 5:00pm (Registration starts at 1:45pm) Venue :
More informationFollowing text taken from Suresh Kumar. Bioinformatics Web - Comprehensive educational resource on Bioinformatics. 6th May.2005
Bioinformatics is the recording, annotation, storage, analysis, and searching/retrieval of nucleic acid sequence (genes and RNAs), protein sequence and structural information. This includes databases of
More informationQuantum Dots and Carbon Nanotubes in Cancer diagnose EE453 Project Report submitted by Makram Abd El Qader
Quantum Dots and Carbon Nanotubes in Cancer diagnose EE453 Project Report submitted by Makram Abd El Qader abdelqad@unlv.nevada.edu, Fall 2008 Abstract On the basis of research and cancer medical treatment,
More informationvfa position paper Nanobiotechnology/Nanomedicine EXECUTIVE SUMMARY
vfa position paper Nanobiotechnology/Nanomedicine EXECUTIVE SUMMARY By international comparison, Germany holds a strong position in the field of nanotechnology. Nanobiotechnology has the potential of opening
More informationGenetics Lecture 21 Recombinant DNA
Genetics Lecture 21 Recombinant DNA Recombinant DNA In 1971, a paper published by Kathleen Danna and Daniel Nathans marked the beginning of the recombinant DNA era. The paper described the isolation of
More informationLUPAS Luminescent Polymers for in vivo Imaging of Amyloid Signatures
LUPAS Luminescent Polymers for in vivo Imaging of Amyloid Signatures A research project for innovative diagnostics for neurodegenerative disorders Funded by the European Union under the 7 th Framework
More informationCancer Nanotechnology and Nanotoxicology: Response to NIH RFAs
Cancer Nanotechnology and Nanotoxicology: Response to NIH RFAs Oct 13, 2015 nanoutah 2015 M.M. Janát-Amsbury, MD, PhD and H. Ghandehari, PhD Obstetrics and Gynecology/Gynecologic Oncology Pharmaceutics
More informationSupport: Ask the scientists how they feel about their research being presented in the media.
Lesson Plans Lesson Format Lesson 4 Science In The Media By now the students will have interacted directly with the scientists. In this lesson, students will consider how they and other members of the
More informationMarie Skłodowska-Curie European Fellowship
Marie Skłodowska-Curie European Fellowship Expression of Interest Application Form 2017 This form must be completed for Expressions of Interest (EoIs) to the Marie Skłodowska-Curie European Fellowship
More informationNANOSCIENCE AND NANOTECHNOLOGIES - Asia Nanoscience And Nanotechnology Development - Chunli Bai
ASIA NANOSCIENCE AND NANOTECHNOLOGY DEVELOPMENT Chunli Bai Chinese Academy of Sciences, China Keywords: Nano, Asia, Brief History, Administration and Implementation Sectors, Policies Characteristics Contents
More informationBioNanoMed March, Krems/Austria
26-28 March, Krems/Austria TOPICS Nanotechnology Enables Personalized Medicine New Frontiers in Medicine & Biology A - Novel Nanomedical Solutions - Advances in Nanomedicine Neurodegenerative Diseases,
More informationTRANSLATIONAL NANOMEDICINE
TRANSLATIONAL NANOMEDICINE St Louis, MO. CORTEX Building Center of Research, Technology, and Entrepreneurial Exchange C-TRAIN @ Washington University Consortium For Translational Research in Advanced Imaging
More informationModule: Key Enabling Technologies for Biomedical Engineering
Module: Key Enabling Technologies for Biomedical Engineering Mandatory Courses New Frontiers in Medical Technology Coordinator: Laura González Credits: 6 This course offers an up-to-date report on current
More informationNEW MOLECULAR IMAGING LABS TO UNDERPIN SINGAPORE S BIOMEDICAL RESEARCH EFFORTS
PRESS RELEASE 20 May 2005 NEW MOLECULAR IMAGING LABS TO UNDERPIN SINGAPORE S BIOMEDICAL RESEARCH EFFORTS 1. The newly minted Singapore Bioimaging Consortium (SBIC) plans to harness existing imaging expertise
More informationNanoscience: A historical perspective R. Díez Muiño and P. M. Echenique Lecture Notes Fall 2007
Nanoscience: A historical perspective R. Díez Muiño and P. M. Echenique Lecture Notes Fall 2007 THE SCALE OF THINGS THE SCALE OF THINGS 1 nano = 10-9 1 nanometer = 10-9 meters The root comes from the Greek
More informationNanotoxicology. Some nanomaterial properties raise toxicity concerns. Small size. High surface area. Fibrous morphology
Nanotoxicology Some nanomaterial properties raise toxicity concerns Small size - small aerodynamic diameter deep lung penetration - high permeability in biological membranes - enhanced cellular uptake
More informationAffinity Reagents: The Landscape and Affimer Technology Competitive Advantages
Affinity Reagents: The Landscape and Affimer Technology Competitive Advantages Introduction It is well accepted that the limitations of antibodies present valuable commercial opportunities for alternative
More information1.0 Background to the organisation
1.0 Background to the organisation The National University of Ireland Galway, the Royal College of Surgeons in Ireland, University College Cork, University College Dublin and Trinity College and their
More informationCentre for Bioactive Molecules and Drug Delivery (BMDD)
Centre for Bioactive Molecules and Drug Delivery (BMDD) Foreword by Prof Mak Joon Wah Professor, Dean, Postgraduate Studies & Research cum Vice-President, Research, School of Postgraduate Studies & Research
More informationBrochure. Medical Nanotechnology Congress. September 03-04, 2018 Tokyo, Japan. conferenceseries.com. 16 th World. Conference Secretariat
conferenceseries.com Brochure 16 th World Medical Nanotechnology Congress Theme: Future Challenges and Advanced Innovations in Nanotechnology September 03-04, 2018 Tokyo, Japan Conference Secretariat 47
More informationPersonalized. Health in Canada
Personalized Health in Canada Canadian Institutes of Health Research Personalized Medicine Signature Initiative 2010-2013 0 Dr. Morag Park CIHR Institute of Cancer Research Dr. Paul Lasko CIHR Institute
More informationNational Center for Nanoscience and Technology, China
National Center for Nanoscience and Technology, China National Center for Nanoscience and Technology, China (NCNST) is co-founded by the Chinese Academy of Sciences and Ministry of Education, on December
More informationBioNanoMed March, Krems/Austria
13-15 March, Krems/Austria TOPICS Nanotechnology Enables Personalized Medicine New Frontiers in Medicine & Biology - Novel Nanomedical Solutions - Advances in Nanomedicine Cancer / Oncology, Neurodegenerative
More informationCarbohydrate Clustering to Bio-sensing Application
Faifan Tantakitti (Student ID 0632263) Application for Mary Gates Research Scholarship 1 November 6, 2009 Carbohydrate Clustering to Bio-sensing Application My motivations for getting involved: Growing
More informationExhibition and Sponsorship Guide. Organizer
Exhibition and Sponsorship Guide Organizer Introduction--- Nanotech France 2018 brings together leading scientists, researchers, engineers, practitioners, technology developers and policy makers in nanotechnology
More informationNIA Open Webinar Nanomedicine: Diagnostics and therapeutics advancing through nanotechnology
NIA Open Webinar Nanomedicine: Diagnostics and therapeutics advancing through nanotechnology 7 March 2018 1500 CET The webinar will start at 1500 CET and we will keep participants on mute during the presentations
More informationNanosensors. Rachel Heil 12/7/07 Wentworth Institute of Technology Department of Electronics and Mechanical Professor Khabari Ph.D.
Nanosensors Rachel Heil 12/7/07 Wentworth Institute of Technology Department of Electronics and Mechanical Professor Khabari Ph.D. There are many advances in nanotechnology that if perfected could help
More informationRegenerative and Immune Engineering Focus Area Upper-Level Engineering Courses updated October, 2018 For BME Class of 2021 and beyond
Regenerative and Immune Engineering Focus Area Upper-Level Engineering Courses updated October, 2018 For BME Class of 2021 and beyond EN.510.311 Structure of Materials 3 EN.510.312 Thermodynamics/Materials
More informationRegenerative and Immune Engineering Focus Area - Upper-Level Engineering Courses updated June, 2018 For BME Class of 2021 and beyond
Regenerative and Immune Engineering Focus Area - Upper-Level Engineering Courses updated June, 2018 For BME Class of 2021 and beyond EN.510.311 Structure of Materials 3 EN.510.312 Thermodynamics/Materials
More informationNANOTHERAPEUTICS. Drug Delivery Concepts in Nanoscience
NANOTHERAPEUTICS Drug Delivery Concepts in Nanoscience This page intentionally left blank NANOTHERAPEUTICS Drug Delivery Concepts in Nanoscience edited by Alf Lamprecht of France PAN STANFORD PUBLISHING
More informationImproving the Limit of Detection of Lateral Flow Assays using 3DNA Technology
Improving the Limit of Detection of Lateral Flow Assays using 3DNA Technology Introduction Lateral Flow (LF) and similar assays represent a unique growing class of Point of Care (POC) tests designed to
More informationNanoAssemblr Benchtop. Develop Future Nanomedicines
NanoAssemblr Benchtop Develop Future Nanomedicines Develop the Future of Medicine Overcome key challenges in advancing nanomedicines: Challenges with conventional production methods Solutions with the
More informationUNCLASSIFIED R-1 ITEM NOMENCLATURE
COST ($ in Millions) All Prior FY 2014 Years FY 2012 FY 2013 # Base FY 2014 FY 2014 OCO ## Total FY 2015 FY 2016 FY 2017 FY 2018 Cost To Complete Total Program Element - 44.445 39.676 49.500-49.500 51.500
More informationDevelopment of new polymeric biomaterials for in vitro and in vivo liver reconstruction
SIXTH FRAMEWORK PROGRAMME PRIORITY 3 NMP- Nanotechnology and nano sciences, knowledge-based multifunctional materials and new production processes and devices Development of new polymeric biomaterials
More informationMolecular Dynamics Simulations of the NF-κB. Inducing Kinase:
Molecular Dynamics Simulations of the NF-κB Inducing Kinase: A Computational Study of the Effects of Mutations and Environmental Stress on Proteins and their Applications to Disease Prevention Joshua Yue
More informationBIOMAN 2015 IMMUNOASSAYS. Barbara Bielska Northampton Community College Tannersville, PA
BIOMAN 2015 IMMUNOASSAYS Barbara Bielska Northampton Community College Tannersville, PA 1 Immunoassays An immunoassay is a biochemical test that measures the presence or concentration of a molecules (typically
More informationRealizing the Future that Regenerative Medicine Will Open
470 Hitachi Review Vol. 65 (2016), No. 9 Featured Articles Realizing the Future that Regenerative Medicine Will Open Shizu Takeda, Ph.D. OVERVIEW: Regenerative medicine is an innovative approach to medicine
More informationBGEN Laboratory Methods in Human and Medical Genetics
BMG COURSES BGEN 7000 - Research Seminar MSc Consists of presentations of the student's current research. For Master s students only. 1.0 credit hours. BGEN 7020 Proteins (Formerly 137.702) Three hours
More informationRadiation engineering - on the fast track towards the development of smart nanodrugs Clelia Dispenza
Radiation engineering - on the fast track towards the development of smart nanodrugs Clelia Dispenza Università degli Studi di Palermo, Italy The nanotechnology revolution in drug delivery Stable and durable
More informationThe University of Alberta Faculty of Engineering
The University of Alberta Faculty of Engineering Engineers use creativity, scientific principles, and technological expertise to develop and advance the products and production methods that define the
More informationINDIAN INSTITUTE OF TECHNOLOGY ROORKEE NPTEL NPTEL ONLINE CERTIFICATION COURSE. Biomedical Nanotechnology. Lec-01 Introduction to Nano
INDIAN INSTITUTE OF TECHNOLOGY ROORKEE NPTEL NPTEL ONLINE CERTIFICATION COURSE Biomedical Nanotechnology Lec-01 Introduction to Nano Dr. P. Gopinath Department of Biotechnology Indian Institute of technology
More informationUNIVERSIDAD DEL PAÍS VASCO / EUSKAL HERRIKO UNIBERSITATEA. Eman ta zabal zazu ESCUELA SUPERIOR DE INGENIEROS DE BILBAO BILBOKO INGENIARIEN GOI ESKOLA
UNIVERSIDAD DEL PAÍS VASCO / EUSKAL HERRIKO UNIBERSITATEA Eman ta zabal zazu ESCUELA SUPERIOR DE INGENIEROS DE BILBAO BILBOKO INGENIARIEN GOI ESKOLA LOW DIMENSIONAL SYSTEMS NANOROBOTS Master in Nanoscience
More informationa) JOURNAL OF BIOLOGICAL CHEMISTRY b) PNAS c) NATURE
a) JOURNAL OF BIOLOGICAL CHEMISTRY b) c) d) ........................ JOURNAL OF BIOLOGICAL CHEMISTRY MOLECULAR PHARMACOLOGY TRENDS IN PHARMACOLOGICAL S AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY
More informationHorizon 2020 funding opportunities for Regenerative Medicine ( ) Rudolf Fryček, PhD.
Horizon 2020 funding opportunities for Regenerative Medicine (2018-2020) Rudolf Fryček, PhD. Disclaimer: Any information mentioned is preliminary only, always consult the official documents. 1 Outline
More informationNanomedicine in Healthcare Forum
Nanomedicine in Healthcare Forum Contact person: Brad Herring Contact information: bradh@ncmls.org General Description Summary: This forum explores nanotechnology-enabled medical technologies and their
More informationLight-Responsive Nanostructured Systems For Applications In Nanomedicine (Topics In Current Chemistry)
Light-Responsive Nanostructured Systems For Applications In Nanomedicine (Topics In Current Chemistry) If you are searched for a ebook Light-Responsive Nanostructured Systems for Applications in Nanomedicine
More informationWHAT DO WE MEAN BY NANOSCIENCE OR NANOTECHNOLOGY EDUCATION?
2nd US-Korea NanoForum, Los Angeles, USA, February 17-19, 2005 WHAT DO WE MEAN BY NANOSCIENCE OR NANOTECHNOLOGY EDUCATION? Donald R. Baer Pacific Northwest National Laboratory don.baer@pnl.gov Talk intended
More informationMASTER IN PHARMACEUTICAL SCIENCES (Thesis Track)
MASTER IN PHARMACEUTICAL SCIENCES (Thesis Track) I. GENERAL RULES CONDITIONS: Plan Number 1 \ 12 70 2005 T 1. This plan conforms to the valid regulations of the programs of graduate studies. 2. Areas of
More informationThe Application of DNA Nanotechnology for Guided Drug Delivery
Tony Wang Professor Scarlatos HON 301 October 19th, 2014 Introduction: The Application of DNA Nanotechnology for Guided Drug Delivery A major problem that exists in drug-based disease treatments is the
More informationGraduate Courses: Advanced Pharmaceutics Prerequisites: Course No: Instructor: Credits: Description:
The following is a listing of courses offered by the Graduate Program in Pharmaceutical Science. Prerequisites and brief descriptions are included for each course. For more information on a particular
More informationSINGAPORE RESEARCHERS DEVELOP WORLD S FIRST HIGH- THROUGHPUT IMAGING PLATFORM FOR PREDICTING KIDNEY TOXICITY
MEDIA RELEASE FOR IMMEDIATE RELEASE 18 JANUARY 2016 SINGAPORE RESEARCHERS DEVELOP WORLD S FIRST HIGH- THROUGHPUT IMAGING PLATFORM FOR PREDICTING KIDNEY TOXICITY Automated cellular imaging platform efficiently
More informationComputational methods in bioinformatics: Lecture 1
Computational methods in bioinformatics: Lecture 1 Graham J.L. Kemp 2 November 2015 What is biology? Ecosystem Rain forest, desert, fresh water lake, digestive tract of an animal Community All species
More informationBuilding the Europe of Knowledge
Building the Europe of Knowledge 7 th Framework Programme 2007-2013 Nanotechnology! All information preliminary! FP7 1. Capacities: Infrastructures 2. People: Erasmus, Marie-Curie 3. Ideas: ERC 4. Cooperation:
More informationIntroduction [1] Introduction to the course; CEO and CLO
MME 297: Lecture 01 Introduction [1] Introduction to the course; CEO and CLO Dr. A. K. M. Bazlur Rashid Professor, Department of MME BUET, Dhaka Topics to discuss today. What are Biomaterials? Classes
More informationCentre for NanoHealth
Steve Conlan PhD An integrated collaborative base for businesses in Wales Director - Reproductive Biology & Cancer Research Institute of Life Science School of Medicine Unique interdisciplinary R&D environment,
More informationTRANSLATIONAL RESEARCH THEORY AND PRACTICE. Ian Weeks Professor in Translational Biochemistry School of Medicine Cardiff University
TRANSLATIONAL RESEARCH THEORY AND PRACTICE Ian Weeks Professor in Translational Biochemistry School of Medicine Cardiff University Translational research: Bench to bedside Not just clinical trials Encompasses
More informationInvitation for Conference
Invitation for Conference Global Summit and Expo on Current Scenario and Future Stem Cell Medicine Website: http://stemcell.scientificsynergy.com/ Email id: contact@scientificsynergy.com stemcell@scientificsynergy.com
More informationThe 2015 Eli Ruckenstein Lecture
The Chemical and Biological Engineering Department of the University at Buffalo School of Engineering and Applied Sciences is Proud to Announce The 2015 Eli Ruckenstein Lecture Biomaterials and biotechnology:
More informationControlled Release Drug Delivery from Hydrogels
Controlled Release Drug Delivery from Hydrogels Teacher s Guide Keith Neeves CSIP Graduate Fellow Cornell University 1 Overview The objective of this project is to introduce students to the concepts of
More informationWhat IMI means for POLAND
What IMI means for POLAND Maciej Bagiński Gdansk University of Technology Deputy of Polish Delegate to IMI SRG History of calls 1 st call 15 projects (395 teams) 281 mln 2 nd call 8 projects (193 teams)
More informationA New Era of Clinical Diagnostics: How the Business Model is Changing.
A New Era of Clinical Diagnostics: How the Business Model is Changing. Nancy J Kelley, President and CEO of Nancy J Kelley & Associates Remarks to BTIG Emerging Technologies in Healthcare Diagnostics September
More informationDETERMINATION OF THE Rh FACTOR BY PCR
DETERMINATION OF THE Rh FACTOR BY PCR Ref.: PCR2 1. EXPERIMENT OBJECTIVE The aim of this experiment is to introduce students to the principles and practice of the Polymerase Chain Reaction (PCR) by studying
More informationStudents should be able to explain how the spread of diseases can be reduced or prevented.
4.3 Infection and response Pathogens are microorganisms such as viruses and bacteria that cause infectious diseases in animals and plants. They depend on their host to provide the conditions and nutrients
More informationBlue Marble University. Fast Track Combination Bachelor of Science (B.S.) and Doctor of Science (D.Sc.) in Biomedical engineering
Blue Marble University Fast Track Combination Bachelor of Science (B.S.) and Doctor of Science (D.Sc.) in Biomedical engineering 5 Year program which you can enter right after High School And Complete
More informationOverview of Research at UCSB. Michael Witherell Vice Chancellor for Research
Overview of Research at UCSB Michael Witherell Vice Chancellor for Research Welcome to UCSB 2 Who supports the research? Extramural funding for FY2006 UCSB ranks 18th among U.S. universities in NSF research
More informationFeature Selection of Gene Expression Data for Cancer Classification: A Review
Available online at www.sciencedirect.com ScienceDirect Procedia Computer Science 50 (2015 ) 52 57 2nd International Symposium on Big Data and Cloud Computing (ISBCC 15) Feature Selection of Gene Expression
More informationRenew, Repair, Rejuvenate. Presented by: Clinton Howard at the 2012 Leadership Retreat Maui, Hawaii, September 29, 2012
Stem-Kine Renew, Repair, Rejuvenate Presented by: Clinton Howard at the 2012 Leadership Retreat Maui, Hawaii, September 29, 2012 I am pleased to have the opportunity to talk with you about one of the most
More informationCANCER RESEARCH: Down to the Basics
CANCER RESEARCH: Down to the Basics At Caltech it is an accepted fact that, in the long run, basic research is often the best kind of applied research. Although the results of a scientist's investigations
More informationHOST DEFENSE SMALL GROUP PROBLEM SOLVING SESSION CLINICAL IMMUNOLOGIC ASSAYS-II
HOST DEFENSE SMALL GROUP PROBLEM SOLVING SESSION CLINICAL IMMUNOLOGIC ASSAYS-II Monday, March 24, 2008 2:00 PM 4:00 PM Small Group Classrooms LEARNING GOAL Understanding in vitro assessment of immunologic
More informationINTRODUCTION TO NANOTECHNOLOGIES AND NANOMATERIALS
INTRODUCTION TO NANOTECHNOLOGIES AND NANOMATERIALS Prof Jim Bridges Chair, Scientific Committee for Emerging and Newly Identified Health Risks (SCENIHR), and Emeritus Professor of Toxicology and Environmental
More informationIntroducing the Department of Life Sciences
Introducing the Department of Life Sciences Life Sciences is a discipline that aims at a fundamental understanding of life phenomena by exploring complex and mysterious structures and funct ions of living
More informationNANOTECHNOLOGY. Promoting awareness for the responsible use and development of OVERVIEW.
Promoting awareness for the responsible use and development of NANOTECHNOLOGY OVERVIEW Nanotechnology holds the promise of solving some age-old problems but also potentially creating some new ones. Successfully
More informationFolic Acid-Conjugated Chitosan Functionalized Gold Nanoparticles for Targeted Delivery of 5-Fluorouracil in Breast Cancer
Proceedings of the 3 rd World Congress on Recent Advances in Nanotechnology (RAN'18) Budapest, Hungary April 10-12, 2018 Paper No. NDDTE 103 DOI: 10.11159/nddte18.103 Folic Acid-Conjugated Chitosan Functionalized
More informationCentre for Synthetic Biology
Centre for Synthetic Biology Preface Introduction The Groningen Centre for Synthetic Biology (CSB) was established to foster research expertise in the emerging field of synthetic biology. It incorporates
More informationA Report on the Molly and David Bloom Chair in Multiple Myeloma Research at the Princess Margaret Cancer Centre
A Report on the Molly and David Bloom Chair in Multiple Myeloma Research at the Princess Margaret Cancer Centre April 2013 Table of Contents 1 Introduction 2 Your Support 3 Thank you 10 The Princess Margaret
More informationApproaches and challenges for the manufacture and scale-out of autologous cell therapies
Loughborough University Institutional Repository Approaches and challenges for the manufacture and scale-out of autologous cell therapies This item was submitted to Loughborough University's Institutional
More informationEngineering Nanomedical Systems
BME 626 November 4, 2014 Engineering Nanomedical Systems Lecture 15 GMP and issues of quality control manufacture of nanodelivery systems James F. Leary, Ph.D. SVM Endowed Professor of Nanomedicine Professor
More informationPresidential Commission for the Study of Bioethical Issues 2 nd meeting September
Presidential Commission for the Study of Bioethical Issues 2 nd meeting September 13 14 2010 David B. Weiner, Ph.D. Professor Department of Pathology and Laboratory Medicine University of Pennsylvania
More informationNanotechnology in the medical field. Alexander Parkes. Paper based on Pathology Lectures Vetsix 2004
Nanotechnology in the medical field By Alexander Parkes Paper based on Pathology Lectures Vetsix 2004 1 Abstract This paper is about the background of Nanotechnology, the current uses of this technology
More informationNational Consultation on Nanomaterials and Their Implications on Human Health and Environment
National Consultation on Nanomaterials and Their Implications on Human Health and Environment Opportunities & Challenges for Nanotechnology in Food John R. Dutcher University of Guelph Nano: The Science
More informationMONASH BIOMEDICINE DISCOVERY INSTITUTE. At a Glance. monash.edu/discovery-institute
MONASH BIOMEDICINE INSTITUTE At a Glance monash.edu/discovery-institute MONASH BIOMEDICINE INSTITUTE WHO WE ARE An institute with the scale and scope to tackle major research questions. We are one of the
More information